Collaborations

Vivomicx is actively looking for partners that are interested in expanding the application area of our technology to cover other disease areas, including cardiovascular disease and CNS. 


We are also interested in co-development partners with relevant expertise to assist us in developing our technology further as a system to be integrated as a screening mechanism in the process of drug discovery & drug development.  


For more information or partnership offers: j.zuidema@vivomicx.eu Vivomicx is collaborating in the field of targeted siRNA delivery with Synvolux (www.synvolux.com). Vivomicx technology analyses in vivo local knock down of genes that is created by selective delivery of siRNA into target (endothelial) cells, and hence assists in showing proof delivery success. Furthermore, it provides clues for downstream consequences of gene knock out in the complex in vivo environment.